AG will be presenting at this year’s UBS Global Life Sciences Conference
in New York City. Dr. Uwe Maschek, CEO of MagForce Nanotechnologies, will provide
an investor overview of the company and discuss the current status of its Nano-Cancer®
therapy. The presentation will take place at the Grand Hyatt New York on September
25, 2008, starting at 11:00 a.m.
The annual UBS Global Life Sciences Conference is one of the world’s
largest investor events within the pharmaceutical, medical technology and biotechnology
sector, with more than 350 companies introducing their latest products and most
promising research and development efforts to institutional investors.
Two days prior to this conference, on September 23 starting at 11:30 a.m.,
Dr. Maschek will deliver a company presentation at AdvaMed 2008 in Washington,
D.C. AdvaMed is the annual conference of the Advanced Medical Technology Association,
the U.S. industry association for medical technology.